Knockdown of integrin α7 prevents cell migration, EMT (N-cadherin upregulation), and FAK activation in S100P overexpressing cancer cells, suggesting that S100P promotes cancer progression by binding integrin α7 and the FAK/AKT signaling pathway. This evidence concerns the gene PTK2 and cancer.